Latest news
Should Gilead’s Swing to a Full‑Year Loss Outlook Require Action From Gilead Sciences (GILD) Investors? - simplywall.stsimplywall.st · Sat, 08 Aug 2026 08:25:24 GMTCan Gilead Sciences (NASDAQ:GILD) Turn Research Into Growth? - Kalkine MediaKalkine Media · Fri, 07 Aug 2026 16:16:00 GMTThe Bull Case For Gilead Sciences (GILD) Could Change Following Deeper 2026 Losses Amid HIV, Oncology Growth - Yahoo FinanceYahoo Finance · Wed, 05 Aug 2026 12:14:01 GMTAHF Crowns Gilead Corporate Welfare King - AIDS Healthcare FoundationAIDS Healthcare Foundation · Tue, 04 Aug 2026 22:02:29 GMTGilead Sciences (NASDAQ:GILD) Beats Expectations in Strong Q2 CY2026 - The Chronicle-JournalThe Chronicle-Journal · Tue, 04 Aug 2026 21:05:00 GMTCalifornia Supreme Court rules Gilead not liable for defective HIV drug claims - Courthouse NewsCourthouse News · Mon, 03 Aug 2026 22:48:29 GMTCalifornia’s highest court rules for Gilead in ‘duty to innovate’ case - WTVBWTVB · Mon, 03 Aug 2026 21:09:41 GMTCalifornia Supreme Court sides with Gilead in ‘duty’ to innovate case - STATSTAT · Mon, 03 Aug 2026 20:59:34 GMT